Basit öğe kaydını göster

Droperidol has comparable clinical efficacy against both nausea and vomiting

dc.contributor.authorTuran, A.
dc.contributor.authorCakmakkaya, O. S.
dc.contributor.authorStader, A.
dc.contributor.authorBiedler, A.
dc.contributor.authorKolodzie, K.
dc.contributor.authorApfel, C. C.
dc.contributor.authorFrings, G.
dc.contributor.authorKranke, P.
dc.contributor.authorMalhotra, A.
dc.date.accessioned2021-03-02T21:58:28Z
dc.date.available2021-03-02T21:58:28Z
dc.date.issued2009
dc.identifier.citationApfel C. C. , Cakmakkaya O. S. , Frings G., Kranke P., Malhotra A., Stader A., Turan A., Biedler A., Kolodzie K., "Droperidol has comparable clinical efficacy against both nausea and vomiting", BRITISH JOURNAL OF ANAESTHESIA, cilt.103, sa.3, ss.359-363, 2009
dc.identifier.issn0007-0912
dc.identifier.othervv_1032021
dc.identifier.otherav_09f741fc-b2f5-4ed0-97eb-b85e815727c8
dc.identifier.urihttp://hdl.handle.net/20.500.12627/12471
dc.identifier.urihttps://doi.org/10.1093/bja/aep177
dc.description.abstractBackground. Droperidol is commonly noted to be more effective at preventing postoperative nausea (PON) than vomiting (POV) and it is assumed to have a short duration of action. This may be relevant for clinical decisions, especially for designing multiple-drug antiemetic regimens.
dc.language.isoeng
dc.subjectAnesteziyoloji
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectANESTEZİYOLOJİ
dc.titleDroperidol has comparable clinical efficacy against both nausea and vomiting
dc.typeMakale
dc.relation.journalBRITISH JOURNAL OF ANAESTHESIA
dc.contributor.departmentUniversity of California System , ,
dc.identifier.volume103
dc.identifier.issue3
dc.identifier.startpage359
dc.identifier.endpage363
dc.contributor.firstauthorID193369


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster